XML 67 R45.htm IDEA: XBRL DOCUMENT v3.20.2
Equity Awards and Instruments (Tables)
9 Months Ended 12 Months Ended
Sep. 30, 2020
Dec. 31, 2019
Share-based Payment Arrangement [Abstract]    
Schedule of Options

The following is a summary of option activity under the Company's applicable equity incentive plans and after giving effect to the $1.50 downward exercise price adjustment as a result of the Special Dividend:

 

 

 

 

 

 

 

 

 

 

 

 

Exercise Price Per Share

 

 

Options

 

 

 

Weighted

 

    

Outstanding

    

Range

    

Average

Balance, December 31, 2019

 

18,691,667

 

$2.00 – $5.74

 

$

4.47

Option activity:

 

  

 

  

 

 

  

Granted

 

10,000

 

9.34

 

 

9.34

Exercised

 

(4,864,944)

 

2.00 – 5.74

 

 

3.37

Canceled

 

(223,250)

 

2.00 – 9.34

 

 

5.30

Balance, September 30, 2020

 

13,613,473

 

$3.73 – $5.74

 

$

4.85

 

The following is a summary of options outstanding and exercisable by exercise price under the Company's applicable equity incentive plans as of September 30, 2020 and after giving effect to the $1.50 downward exercise price adjustment as a result of the Special Dividend:

 

 

 

 

 

 

 

 

    

 

    

Weighted

    

    

 

 

 

 

Remaining

 

 

 

 

Number of

 

Contractual

 

 

Exercise

 

Options

 

Life

 

 

Prices

 

Outstanding

 

(in years)

 

Exercisable

$3.73 – $4.00

 

5,407,315

 

1.07

 

4,424,881

4.01 – 5.74

 

8,206,158

 

3.08

 

2,536,658

Total

 

13,613,473

 

 

 

6,961,539

 

For the year ended December 31, 2019 and the nine months ended September 30, 2020, the Company received cash proceeds of $3,612 and $7,776, respectively, related to the exercise of stock options.

The following is a summary of the intrinsic value of options outstanding and exercisable under the Company's applicable equity incentive plans as of September 30, 2020 and after giving effect to the $1.50 downward exercise price adjustment as a result of the Special Dividend:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted

 

 

 

 

Weighted

 

 

 

 

Remaining

 

 

 

 

Average

 

Aggregate

 

Contractual

 

 

Number of

 

Exercise

 

Intrinsic

 

Life

 

    

Options

    

Price

    

Value

    

(in years)

Options as of September 30, 2020

 

  

 

 

  

 

 

  

 

  

Outstanding

 

13,613,473

 

$

4.85

 

$

361,441

 

2.3

Exercisable

 

6,961,539

 

$

4.40

 

$

187,962

 

1.7

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Exercise Price Per Share

 

    

Options

    

 

 

 

 

 

    

Weighted

 

 

Outstanding

 

Range

Average

Balance, December 31, 2017

 

18,629,380

 

$

0.31

-

$

5.38

 

$

3.72

Option activity:

 

  

 

 

 

 

 

  

 

 

  

Granted

 

5,126,000

 

 

6.81

-

 

8.67

 

 

6.81

Exercised

 

(3,738,182)

 

 

0.31

-

 

5.38

 

 

1.89

Canceled

 

(502,750)

 

 

0.31

-

 

8.67

 

 

5.04

Balance, December 31, 2018

 

19,514,448

 

$

1.79

-

$

6.81

 

$

4.85

Option activity:

 

  

 

 

 

 

 

  

 

 

  

Granted

 

4,826,000

 

 

 

 

 

7.24

 

 

7.24

Exercised

 

(4,731,158)

 

 

1.79

-

 

6.81

 

 

2.68

Canceled

 

(917,623)

 

 

1.79

-

 

7.24

 

 

5.82

Balance, December 31, 2019

 

18,691,667

 

$

3.50

-

$

7.24

 

$

5.97

 


The following is a summary of options outstanding and exercisable by exercise price as of December 31, 2019:

 

 

 

 

 

 

 

 

    

 

    

Weighted

    

 

 

 

Number of

 

Remaining

 

 

 

 

Options

 

Contractual

 

 

Exercise Prices

 

Outstanding

 

Life (in years)

 

Exercisable

$3.50 – $4.00

 

1,978,256

 

0.39

 

1,978,256

4.01 – 6.00

 

7,450,203

 

1.78

 

4,469,866

$6.01 – $7.24

 

9,263,208

 

3.82

 

1,125,708

Total

 

18,691,667

 

  

 

7,573,830

 


The following is a summary of the intrinsic value of options outstanding and exercisable as of December 31, 2019:

 

 

 

 

 

 

 

 

 

 

 

 

    

 

    

 

 

    

 

 

    

Weighted

 

 

 

 

Weighted

 

Aggregate

 

Remaining

 

 

Number of

 

Average

 

Intrinsic

 

Contractual

 

 

Options

 

Exercise Price

 

Value

 

Life (in years)

Options as of December 31, 2019

 

  

 

 

  

 

 

  

 

  

Outstanding

 

18,691,667

 

$

5.97

 

$

91,028

 

2.6

Exercisable

 

7,573,830

 

$

5.05

 

$

43,852

 

1.6

 

Schedule of assumptions used to estimate the fair value of the share options granted

 

 

 

 

 

 

 

 

 

    

Year Ended

    

Nine Months Ended

 

 

 

December 31,

 

September 30,

 

 

    

2019

    

2020

 

Expected volatility

 

 

29.57

%  

 

31.04

%

Expected dividend yield

 

 

1.38

%  

 

1.11

%

Risk-free interest rate

 

 

2.48

%  

 

1.31

%

Expected term (in years)

 

 

3.75

 

 

3.75

 

Weighted average grant date fair value of options issued

 

$

1.66

 

$

2.49

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Year Ended December 31, 

 

 

 

 

2018

 

 

2019

 

Expected volatility

 

 

26.32% – 27.18

%  

 

 

29.57

%

Expected dividend yield

 

 

1.18

%  

 

 

1.38

%

Risk-free interest rate

 

 

2.40

%  

 

 

2.48

%

Expected term (in years)

 

 

3.75

 

 

 

3.75

 

Weighted average grant date fair value of options issued

 

$

1.46

 

 

$

1.66